“…They exhibit broad-spectrum antimicrobial activity against Gram-positive and Gram-negative pathogens and Mycoplasma spp. (Spreng, Deleforge, Thomas, Boisrame, & Drugeon, 1995;Thomas, Nicolas, Dizier, Mainil, & Linden, 2003), low toxicity, and limited development of bacterial resistance (Nie et al, 2016). Therefore, MBF and OFX are intensively applied for the treatment of various human and animal infectious diseases, such as urinary tract infection, respiratory tract infection, and osteomyelitis (Cotard et al, 1995;Potter, Illambas, Pelligand, Rycroft, & Lees, 2013;Sidhu, Landoni, Aliabadi, & Lees, 2010).…”